Keyphrases
Tolerability
100%
Intravenous Administration
100%
Postmenopausal Osteoporosis
100%
Administration Study
100%
Ibandronate
100%
Bone Mineral Density
42%
Placebo
28%
Intravenous Injection
28%
Lumbar Spine
28%
Osteoporosis
28%
Proximal Femur
28%
Femur Bone
28%
Randomized Double-blind
14%
Serum Concentration
14%
Vitamin D
14%
Menopause
14%
Bone Resorption
14%
Type I Collagen
14%
T-score
14%
Biochemical Markers
14%
Bone Turnover Markers
14%
New Treatment Options
14%
Lumbar Bone Mineral Density
14%
α-Chain
14%
Daily Regimen
14%
C-telopeptide
14%
Oral Therapy
14%
Oral Dosing
14%
Double Dummy
14%
Non-inferiority Study
14%
Intravenous Bisphosphonates
14%
Injection Schedules
14%
Pharmacology, Toxicology and Pharmaceutical Science
Tolerability
100%
Postmenopause Osteoporosis
100%
Ibandronic Acid
100%
Placebo
28%
Vitamin D
14%
Bisphosphonic Acid Derivative
14%
Biochemical Marker
14%
Collagen Type 1
14%
Telopeptide
14%